Patent
Metal complexes
| العنوان: | Metal complexes |
|---|---|
| Patent Number: | 9,212,198 |
| تاريخ النشر: | December 15, 2015 |
| Appl. No: | 13/395473 |
| Application Filed: | August 18, 2010 |
| مستخلص: | The present invention relates to metal complexes having high solubility and to electronic devices, in particular organic electroluminescent devices, containing these metal complexes. |
| Inventors: | Franz, Adam W. (Kelkheim, DE); Anémian, Rémi Manouk (Seoul, KR) |
| Assignees: | Merck Patent GmbH (Darmstadt, DE) |
| Claim: | 1. A compound of the formula (1) M(L) n (L′) m formula (1) where the compound contains a moiety M(L) n of the formula (2) or formula (3): [chemical expression included] where the following applies to the symbols and indices used: M is a metal selected from the group consisting of iridium, rhodium, platinum and palladium; X and X 1 are, identically or differently on each occurrence, CR 1 or N; Q is, identically or differently on each occurrence, R 1 C═CR 1 , R 1 C═N, O, S, Se or NR 1 ; V is, identically or differently on each occurrence, O, S, Se or NR 1 ; Y is, identically or differently on each occurrence, a single bond or a divalent group selected from C(R 1) 2 , C(═O), O, S, SO, SO 2 , NR 1 , PR 1 or P(═O)R 1 ; R is selected from the groups of the following formulae (8) to (24): [chemical expression included] [chemical expression included] [chemical expression included] R 1 is, identically or differently on each occurrence, H, D, F, Cl, Br, I, N(R 2) 2 , CN, NO 2 , Si(R 2) 3 , B(OR 2) 2 , C(═O)R 2 , P(═O)(R 2) 2 , S(═O)R 2 , S(═O) 2 R 2 , OSO 2 R 2 , a straight-chain alkyl, alkoxy or thioalkoxy group having 1 to 40 C atoms or a straight-chain alkenyl or alkynyl group having 2 to 40 C atoms or a branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or thioalkoxy group having 3 to 40 C atoms, each of which is optionally substituted by one or more radicals R 2 , where one or more non-adjacent CH 2 groups is optionally replaced by R 2 C═CR 2 , C≡C, Si(R 2) 2 , Ge(R 2) 2 , Sn(R 2) 2 , C═O, C═S, C═Se, C═NR 2 , P(═O)(R 2), SO, SO 2 , NR 2 , O, S or CONR 2 and where one or more H atoms is optionally replaced by D, F, Cl, Br, I, CN or NO 2 , or an aryloxy or heteroaryloxy group having 5 to 60 aromatic ring atoms, which is optionally substituted by one or more radicals R 2 , or a diarylamino group, diheteroarylamino group or arylheteroarylamino group having 10 to 40 aromatic ring atoms, which is optionally substituted by one or more radicals R 2 , or a combination of two or more of these groups; R 2 is, identically or differently on each occurrence, H, D, F, Cl, Br, I, N(R 3) 2 , CN, NO 2 , Si(R 3) 3 , B(OR 3) 2 , C(═O)R 3 , P(═O)(R 3) 2 , S(═O)R 3 , S(═O) 2 R 3 , OSO 2 R 3 , a straight-chain alkyl, alkoxy or thioalkoxy group having 1 to 40 C atoms or a straight-chain alkenyl or alkynyl group having 2 to 40 C atoms or a branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or thioalkoxy group having 3 to 40 C atoms, each of which is optionally substituted by one or more radicals R 3 , where one or more non-adjacent CH 2 groups is optionally replaced by R 3 C═CR 3 , C≡C, Si(R 3) 2 , Ge(R 3) 2 , Sn(R 3) 2 , C═O, C═S, C═Se, C═NR 3 , P(═O)(R 3), SO, SO 2 , NR 3 , O, S or CONR 3 and where one or more H atoms is optionally replaced by D, F, Cl, Br, I, CN or NO 2 , or an aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms, each of which is optionally substituted by one or more radicals R 3 , or an aryloxy or heteroaryloxy group having 5 to 60 aromatic ring atoms, which is optionally substituted by one or more radicals R 3 , or a diarylamino group, diheteroarylamino group or arylheteroarylamino group having 10 to 40 aromatic ring atoms, which is optionally substituted by one or more radicals R 3 , or a combination of two or more of these groups; or two or more adjacent radicals R 2 optionally form a mono- or polycyclic, aliphatic or aromatic ring system with one another; R 3 is, identically or differently on each occurrence, H, D, F or an aliphatic, aromatic and/or heteroaromatic hydrocarbon radical having 1 to 20 C atoms, in which, in addition, one or more H atoms is optionally replaced by F; two or more substituents R 3 here optionally form a mono- or polycyclic, aliphatic or aromatic ring system with one another; R 4 is, identically or differently on each occurrence, H or D; L′ is, identically or differently on each occurrence, a co-ligand; n is 1, 2 or 3 when M is iridium or rhodium and is 1 or 2 when M is platinum or palladium; m is 0, 1, 2, 3 or 4; and optionally a plurality of ligands L linked to one another or linked to L′ via bridge Z to form a tridentate, tetradentate, pentadentate or hexadentate ligand system. |
| Claim: | 2. The compound according to claim 1 , wherein the symbol X stands, identically or differently on each occurrence, for CR 1 . |
| Claim: | 3. The compound according to claim 1 , wherein all symbols X1 stand, identically or differently on each occurrence, for CR1 or in that all symbols X1 stand for N. |
| Claim: | 4. The compound according to claim 1 , wherein the symbol Y stands, identically or differently on each occurrence, for a single bond or a divalent group selected from C(═O) or NR1. |
| Claim: | 5. The compound according to claim 1 , wherein the symbol Y stands, identically or differently on each occurrence, for a single bond. |
| Claim: | 6. The compound according to claim 1 , wherein M is iridium or platinum; X is, identically or differently on each occurrence, CR 1 ; X 1 is selected so that all symbols X 1 stand, identically or differently on each occurrence, for CR 1 or in that all symbols X 1 stand for N; Q is, identically or differently on each occurrence, R 1 C═CR 1 or R 1 C═N; V is, identically or differently on each occurrence, O, S or NR 1 ; Y is, identically or differently on each occurrence, a single bond or a divalent group selected from C(═O) or NR 1 ; and R 4 is H. |
| Claim: | 7. The compound according to claim 1 , wherein M is iridium; X is, identically or differently on each occurrence, CR 1 ; X 1 is selected so that all symbols X 1 stand, identically or differently on each occurrence, for CR 1 or in that all symbols X 1 stand for N; Q is, identically or differently on each occurrence, R 1 C═CR 1 ; V is, identically or differently on each occurrence, S; Y is, identically or differently on each occurrence, a single bond; and R 4 is H. |
| Claim: | 8. The compound according to claim 1 , wherein the moieties of the formula (2) or (3) are selected from the moieties of the following formulae (4), (5), (6) and (7): [chemical expression included] other symbols used have the meanings given in claim 1 . |
| Claim: | 9. The compound according to claim 1 , wherein the symbol R stands, identically or differently on each occurrence, for a straight-chain alkyl group having 1 to 10 C atoms or for a branched or cyclic alkyl group having 3 to 10 C atoms, each of which is optionally substituted by one or more radicals R 1 , and where one or more non-adjacent CH 2 groups is optionally replaced by O and where one or more H atoms is optionally replaced by D, F or CN, or an aromatic or heteroaromatic ring system having 5 to 30 aromatic ring atoms, which optionally in each case is substituted by one or more radicals R 1 . |
| Claim: | 10. The compound according to claim 1 , wherein the symbol R stands, identically or differently on each occurrence, for a straight-chain alkyl group having 1 to 10 C atoms or for a branched or cyclic alkyl group having 3 to 10 C atoms, each of which is optionally substituted by one or more radicals R 1 , and where one or more non-adjacent CH 2 groups is optionally replaced by O and where one or more H atoms is optionally replaced by D, F or CN, or an aromatic or heteroaromatic ring system having 5 to 20 aromatic ring atoms, which optionally in each case is substituted by one or more radicals R 1 . |
| Claim: | 11. The compound according to claim 1 , wherein the compound is of the formulae (25) to (28): [chemical expression included] where the symbols used have the meanings given in claim 1 , and Z represents a bridging unit containing 1 to 80 atoms from the third, fourth, fifth and/or sixth main group (IUPAC group 13, 14, 15 or 16) or a 3- to 6-membered homo- or heterocycle which covalently bonds the part-ligands L to one another or L to L′. |
| Claim: | 12. The compound according to claim 1 , wherein the ligand L′ is selected from the group consisting of carbon monoxide, nitrogen monoxide, alkyl cyanides, aryl cyanides, alkyl isocyanides, aryl isocyanides, amines, phosphines, phosphites, arsines, stibines, nitrogen-containing heterocycles, carbenes, hydride, deuteride, the halides F − , Cl − , Br − and I − , alkylacetylides, arylacetylides, cyanide, cyanate, isocyanate, thiocyanate, isothiocyanate, aliphatic or aromatic alcoholates, aliphatic or aromatic thioalcoholates, amides, carboxylates, aryl groups, O 2− , S 2− , carbides, nitrenes, N 3− , diamines, imines, diimines, heterocycles containing two nitrogen atoms, diphosphines, 1,3-diketonates derived from 1,3-diketones, 3-ketonates derived from 3-ketoesters, carboxylates derived from aminocarboxylic acids, salicyliminates derived from salicylimines, dialcoholates derived from dialcohols, borates of nitrogen-containing heterocycles; or selected from bidentate ligands which are composed of the combination of two groups of the following formulae (42) to (69), where one group is bonded via a neutral nitrogen atom or a carbene atom and the other group is bonded via a negatively charged carbon atom or a negatively charged nitrogen atom, and the ligand L′ is formed from the groups of the formulae (42) to (69) by these groups bonding to one another, in each case at the position denoted by #, [chemical expression included] [chemical expression included] [chemical expression included] where * indicates the position of the coordination to the metal, and the symbols used have the meanings described in claim 1 ; or selected from η 5 -cyclopentadienyl, η 5 -pentamethylcyclopentadienyl, η 6 -benzene or η 7 -cycloheptatrienyl, each of which is optionally substituted by one or more radicals R 1 ; or selected from 1,3,5-cis-cyclohexane derivatives, 1,1,1-tri(methylene)-methane derivatives or 1,1,1-trisubstituted methanes. |
| Claim: | 13. The compound according to claim 1 , wherein the ligand L′ is selected from the group consisting of halophosphines, trialkylphosphines, triarylphosphines or alkylarylphosphines. |
| Claim: | 14. A process for the preparation of the compound according to claim 1 which comprises reacting the corresponding free ligands with metal alkoxides of the formula (74), with metal ketoketonates of the formula (75), with metal halides of the formula (76) or with dimeric metal complexes of the formula (77): [chemical expression included] where the symbols M, m, n and R 1 have the meanings indicated in claim 1 , and Hal=F, Cl, Br or I. |
| Claim: | 15. An electronic device comprising at least one compound according to claim 1 . |
| Claim: | 16. The electronic device as claimed in claim 15 , wherein the device is selected from the group consisting of an organic electroluminescent device (OLED, PLED), an organic integrated circuit (O-IC), an organic field-effect transistor (O-FET), an organic thin-film transistor (O-TFT), an organic light-emitting transistor (O-LET), an organic solar cell (O-SC), an organic optical detector, an organic photoreceptor, an organic field-quench device (O-FQD), a light-emitting electrochemical cell (LEC) and an organic laser diode (O-laser). |
| Claim: | 17. An organic electroluminescent device comprising a compound according to claim 1 as an emitting compound in one or more emitting layers in combination with a matrix material. |
| Claim: | 18. The organic electroluminescent device as claimed in claim 17 , wherein the matrix material is selected from the group consisting of ketone, phosphine oxide, sulfoxide, sulfone, triarylamine, carbazole derivative, indolocarbazole derivative, indenocarbazole derivative, azacarbazole derivative, bipolar matrix material, silane, azaborole, boronic ester, triazine derivative, zinc complex, diaza- or tetraazasilole derivatives, diazaphosphole derivative, dibenzofuran derivative and any one mixture of matrix materials. |
| Claim: | 19. A solution or formulation comprising at least one compound according to claim 1 and one or more solvents. |
| Patent References Cited: | 2004/0137263 July 2004 Burn et al. 2005/0247911 November 2005 Burn et al. 2006/0127696 June 2006 Stossel et al. 2006/0220004 October 2006 Stossel et al. 2008/0009627 January 2008 Tsuboyama et al. 2008/0220265 September 2008 Xia et al. 2008/0280163 November 2008 Kwong et al. 2007214175 August 2007 2008013700 January 2008 2008-40111 October 2008 WO-2008/140657 November 2008 WO-2009/005272 January 2009 WO-2009/073245 June 2009 |
| Other References: | International Search Report for PCT/EP2010/005056 mailed Oct. 21, 2010. cited by applicant English translation of Japanese Office Action mailed on Oct. 7, 2014 for Patent Application No. 2012-529135. cited by applicant Taiwan Office Action and IPO Search Report for 099130874 dated Jun. 23, 2014. cited by applicant |
| Primary Examiner: | Wilson, Michael H |
| Attorney, Agent or Firm: | Drinker Biddle & Reath LLP |
| رقم الانضمام: | edspgr.09212198 |
| قاعدة البيانات: | USPTO Patent Grants |
| الوصف غير متاح. |